-
1دورية أكاديمية
المساهمون: Il Joo Kwon, Taehee Kim, Dae San Yoo, Seoyeon Min, Soo-Chan Kim, Jong Hoon Kim, Kim, Soo Chan
مصطلحات موضوعية: Adrenal Cortex Hormones / therapeutic use, Humans, Omalizumab* / therapeutic use, Pemphigoid, Bullous* / chemically induced, Bullous* / drug therapy, Recurrence, Retrospective Studies, Rituximab / adverse effects, autoimmune skin disease, biologics, bullous pemphioid, omalizumab, rituximab
العلاقة: JOURNAL OF DERMATOLOGY; J01372; OAK-2023-01684; OAK-2023-01685; https://ir.ymlib.yonsei.ac.kr/handle/22282913/195402Test; T202303108; JOURNAL OF DERMATOLOGY, Vol.50(5) : 705-709, 2023-05
الإتاحة: https://doi.org/10.1111/1346-8138.16678Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/195402Test -
2دورية أكاديمية
المؤلفون: Fenne, Inger Johanne, Askildsen Oftebro, Guro, Vestergaard, Christian, Frølunde, Anne Sofie, Bech, Rikke
المصدر: Fenne , I J , Askildsen Oftebro , G , Vestergaard , C , Frølunde , A S & Bech , R 2023 , ' Effect of early initiation of steroid-sparing drugs in patients with bullous pemphigoid ' , Frontiers in Immunology , vol. 14 , 1176284 . https://doi.org/10.3389/fimmu.2023.1176284Test
مصطلحات موضوعية: Glucocorticoids/therapeutic use, Humans, Pemphigoid, Bullous/chemically induced, Prednisolone/adverse effects, Recurrence, Retrospective Studies, Steroids/therapeutic use
الإتاحة: https://doi.org/10.3389/fimmu.2023.1176284Test
https://pure.au.dk/portal/en/publications/dab78657-6f05-47fd-8afd-cae167181b3eTest -
3دورية أكاديمية
المصدر: http://lobid.org/resources/99370677062806441Test#!, 22(1):117-127.
مصطلحات موضوعية: Aged, 80 and over [MeSH], Aged [MeSH], Dermatology, Autoantibodies/immunology [MeSH], Skin/pathology [MeSH], Pemphigoid, Bullous/diagnosis [MeSH], Male [MeSH], Bullous/immunology [MeSH], Bullous/blood [MeSH], Bullous/chemically induced [MeSH], Original Research Article, Pharmacotherapy, Female [MeSH], Pharmacology/Toxicology, Skin/immunology [MeSH], Autoantibodies/blood [MeSH], Humans [MeSH], Severity of Illness Index [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Non-Fibrillar Collagens/immunology [MeSH], Dystonin/immunology [MeSH], Sitagliptin Phosphate/adverse effects [MeSH], Vildagliptin/adverse effects [MeSH], Autoantigens/immunology [MeSH], Dipeptidyl-Peptidase IV Inhibitors/adverse effects [MeSH]
العلاقة: https://repository.publisso.de/resource/frl:6465083Test; https://doi.org/10.1007/s40257-020-00563-7Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847447Test/
الإتاحة: https://doi.org/10.1007/s40257-020-00563-7Test
https://repository.publisso.de/resource/frl:6465083Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847447Test/